The purpose of this discussion is to demonstrate your understanding of the characteristics of the doctor of nursing practice-prepared nurse and the skills inherent to your future role as a DNP-prepared nurse

The purpose of this discussion is to demonstrate your understanding of the characteristics of the doctor of nursing practice-prepared nurse and the skills inherent to your future role as a DNP-prepared nurse.

The Global Burden of Disease drives the work of the DNP-prepared nurse as the consummate consumer of research. You will work to find solutions through iterative searching of evidence to address pressing issues.

Instructions

  1. Share your views on the unique characteristics of the DNP-prepared nurse.
  2. The Global Burden of Disease and National Practice Problems are the focus of your ongoing work as a DNP-prepared nurse. The National Practice Problems are multifaceted and complex in nature.
  3. As you consider one of these complex practice problems, explain which of them would you consider examining and why. Remember to keep a limited scope of a problem you would consider working on with the interprofessional team.
  4. Provide key points on why recently published research studies supply the solutions to the practice problem you are considering.

Bacteria stop spreading when they reach an area of greater antibiotic concentration

Bacteria stop spreading when they reach an area of greater antibiotic concentration. Some start spreading again when they gain a mutation that lets them. Why don’t all of the bacteria just develop the mutation and keep spreading right away?

Medical history of significant lupus erythematosus

A 38-year-old female with a past medical history of significant lupus erythematosus (SLE) and hypertension, presents to her Primary Care Physician (PCP) for a wellness visit.  On physical exam, she is in no distress, VS BP 160/80mmHg (normal takes metoprolol and lisinopril but forgets from time to time) HR 80bpm RR 20/min.

Laboratory results show Hgb 14g/dl, WBC 5.0k, Platelets 160K, Cr. 1.80, eGFR 48ml/min.  She denies fevers, chills.  Denies diarrhea.  The patient is concerned about her elevated Cr and ask the PCP a few questions.

Q1:  Compare the etiology of Acute and Chronic Kidney Disease?

Q2:  Describe the mechanism for Acute Kidney Injury in Acute Tubular Necrosis.

Evidence that galanin in the MPOA affects mouse parental behavior includes that

Evidence that galanin in the MPOA affects mouse parental behavior includes that

a. galanin is differentially expressed in the MPOA when parental behavior is expressed.

b. loss of MPOA galanin reduces maternal behavior.

c. optogenetic stimulation of MPOA galanin neurons increases pup grooming duration in fathers

d. a and b e. all of the above

What information can immunohistochemistry provide that a histological stain such as Cresyl Violet or a fluorescent dye like DAPI cannot?

What information can immunohistochemistry provide that a histological stain such as Cresyl Violet or a fluorescent dye like DAPI cannot? Why might you still use a stain like DAPI in conjunction with immunohistochemistry?

Renal GU Progressive case study The nurse is admitting a 74-year-old female, KB, to the emergency department

Renal GU Progressive case study The nurse is admitting a 74-year-old female, KB, to the emergency department. She has a 4-day-long history of non-localized abdominal pain, incontinence, new-onset mental confusion, and lethargy.

Her most current vital signs are BP 82/38, HR 118 and irregular, RR 28, Temp 100.9 degrees, room air oxygen saturation 89%.

 

PMH:

Renal calculi

CHF with an EF of 28%

s/p MI with stent in 5/2020

Afib

HTN

DM 2

Height: 5’8″

Weight: 220 lbs

Allergies: Sulfa drugs, Codeine

Serum Lab review:

Bun 38 mg/dL

Creat 4.2 mg/dL

GFR: 25 ml/min/1.73m2

Sodium: 114 mEq/L

Potassium: 7.1 mEq/L

Glucose: 320 mg/dL

 

White Blood Cells: 15,000/mm3

Hct: 48%

Hgb: 18g/dL

Platelet: 180,000/mm3

Urinalysis:

Appearance: dark amber, cloudy with sediment

Ph 6.9

Specific Gravity: 1.026

Protein: Moderate

Nitrates: Positive

WBC’s: many

RBC’s: many

 

Current Medications:

Aspirin, 81mg PO, QD

Plavix, 75mg PO QD

Eliquis, 5mg, PO, QD

Digoxin, 0.25mg PO, QD

Atenolol, 100mg PO, BID

Lisinopril, 20mg PO, QD

Aldactone, 100mg PO, QD

Metformin, 500mg PO, BID

Sliding scale Regular Insulin AC

 

  1. What are some medical problems that could be going on with KB, and what is the rationale?
  2. What is your interpretation of the serum lab values, and why?
  3. What is your interpretation of the urinalysis, and why?
  4. Why do you think she is taking her current medication and why? Are there any medication you would expect to be changed at this time, on admission, why?

 

The health care provider (HCP) orders are as follows:

The health care provider (HCP) orders are as follows:What is the rationale for this order and is it appropriate/safe?Which are the top 3 priorities
Titrate O2 via NC to maintain O2 saturation greater than 92%
Morphine, 2mg IV push x1
NS @ 200ml/hr x 8 hours
Heparin IV drip: 850 units/hour
EKG
Regular insulin, 12 units, SC

 

KB had all orders implemented. She is admitted to the ICU. A KUB and CT scan were performed and a 4.5mm stone was located in the left kidney, a ECSL was performed. An indwelling Foley catheter was placed. Her BP continued to decline, and she was placed on blood pressure support medicine, intravenously.

Her BUN/Creat continued to increase (BUN 48, Creat 4.9) and GFR continued to decrease (GFR 12). A decision was made to place temporary dialysis catheters in the subclavian.

  1. What do you think is happening?
  2. How do you know?
  3. What other nursing interventions would be implemented, and why?

 

Forty-eight hours later, KB’s status is unchanged.  She continues to feel lethargic and has been receiving hemodialysis daily. Below is the current report from the night shift, items in red are new results.

 

PMH:

Renal calculi

CHF with an EF of 28%

s/p MI with stent in 5/2020

Afib

HTN

DM 2

Height: 5’8″

AdmissionWeight: 220 lbs

Current weight: 250lbs

Allergies: Sulfa drugs, Codeine

Serum Lab review:

Bun 52 mg/dL

Creat 5.2 mg/dL

GFR: 18 ml/min/1.73m2

Sodium: 114 mEq/L

Potassium: 6.1 mEq/L

Glucose: 120 mg/dL

 

White Blood Cells: 8,000/mm3

Hct: 28%

Hgb: 8 g/dL

Platelet: 180,000/mm3

Urinalysis:

Appearance: yellow with slight sediment

Ph 5.9

Specific Gravity: 1.013

Protein: Moderate

Nitrates: negative

WBC’s: none

RBC’s: none

Current Medications:

Aspirin, 81mg PO, QD

Plavix, 75mg PO QD

Eliquis, 5mg, PO, QD

Digoxin, 0.25mg PO, QD

Atenolol, 100mg PO, BID

Lisinopril, 20mg PO, QD

Aldactone, 100mg PO, QD

Metformin, 500mg PO, BID

Sliding scale Regular Insulin AC

Heparin, IV drip, titrate per PTT sliding scale

Procrit 3,000 units/ml three times/week

Lasix, 40mg PO, BID

Aluminum hydroxide (Amphojel), 25mg PO, AC

NS @ 75ml/hr

Vancomycin, 1g, IV QD

Coumadin, 5mg, PO QD

 

  1. Why are the lab values and current weight important?
  2. Why do you think changes were made in the client’s medications?

 

KB remained in the hospital and slowly her status improved.  Unfortunately, her kidneys will not recover. You are providing discharge teaching with the client and her daughter. You prepared a discharge teaching packet, knowing renal failure is a new diagnosis for her.

  1. What do you include, and why?
  2. Below are the discharge medications. Provide brief patient education on the 4 new medications.

 

Dischage Medications:

Aspirin, 81mg PO, QD

Plavix, 75mg PO QD

Digoxin, 0.25mg PO, QD

Atenolol, 100mg PO, BID

Metformin, 500mg PO, BID

Sliding scale Regular Insulin AC

Procrit 3,000 units/ml three times/week during dialysis

Lasix, 40mg PO, BID

Aluminum hydroxide (Amphojel), 25mg PO, AC

Coumadin, 5mg, PO QD

Explain how the substrate used for the assay of beta-galactosidase activity differs chemically from the artificial inducer used to “switch on” the lac operon.

Explain how the substrate used for the assay of beta-galactosidase activity differs chemically from the artificial inducer used to “switch on” the lac operon.

Which of the following is most likely a sign or symptom of acromegaly?

Which of the following is most likely a sign or symptom of acromegaly?

a. peripheral neuropathy

b. aphasia

c. hyperactivity

d. melena

Transplantation of the SCN between wild-type and tau mutant mice then raised in constant dim light

  1. Transplantation of the SCN between wild-type and tau mutant mice then raised in constant dim light showed that
    A.tau is a property inherent in the SCN.
    B.the SCN can set circadian rhythms via humoral output.
    C.the SCN must have neural connections for tau to be exhibited.

What would be an appropriate prediction for this hypothesis?

What would be an appropriate prediction for this hypothesis? Increased color intensity increases a person’s perception of flavor intensity using commonly associated color-flavor pairs.